All In Biotech

Drug Trial Radar · NCT06264453

A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-designed, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

Last checked: Nov 19, 2026Latest source record: Mar 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 171 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

171

Actual

Start

Mar 19, 2024

Primary completion

Sep 25, 2024

Study completion Sep 25, 2024

Sponsor

Lead sponsor
HysensBio Co., LtdIndustry
Sponsor type
Industry
First posted
Feb 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of KH001 in patients with dentin hypersensitivity.

Conditions

  • Dentin Hypersensitivity

Interventions

  • KH001Drug

    topical applications of KH001

  • PlaceboDrug

    topical applications of Water for Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Schiff sensitivity scoreTime frame: Baseline and Day 36

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kyung Hee University Dental Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.